HEARTBEAM INC (BEAT) Stock Price, Quote, News and Overview
NASDAQ:BEAT - Nasdaq - US42238H1086 - Common Stock - Currency: USD
BEAT Quote, Performance and Key Statistics
NASDAQ:BEAT (4/29/2025, 11:57:39 AM)
1.77
-0.18 (-9.23%)
The current stock price of BEAT is 1.77 USD. In the past year, price decreased by -11.76%.
BEAT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.26 | 225.98B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.82 | 182.89B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.91 | 151.38B | ||
| SYK | STRYKER CORP | 30.24 | 140.68B | ||
| MDT | MEDTRONIC PLC | 15.86 | 108.59B | ||
| BDX | BECTON DICKINSON AND CO | 14.81 | 59.16B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.09 | 44.46B | ||
| IDXX | IDEXX LABORATORIES INC | 38.54 | 35.14B | ||
| RMD | RESMED INC | 25.95 | 34.61B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.04 | 30.91B | ||
| DXCM | DEXCOM INC | 42.74 | 27.65B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.98 | 23.59B |
Related stock screener links
About BEAT
Company Profile
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 21 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Company Info
HEARTBEAM INC
2118 Walsh Ave., Suite 210
Santa Clara CALIFORNIA 19355 US
CEO: Joseph H. Capper
Employees: 15
Company Website: https://www.heartbeam.com/
Investor Relations: https://ir.heartbeam.com/
Phone: 14088994443
HEARTBEAM INC / BEAT FAQ
What is the stock price of HEARTBEAM INC today?
The current stock price of BEAT is 1.77 USD. The price decreased by -9.23% in the last trading session.
What is the ticker symbol for HEARTBEAM INC stock?
The exchange symbol of HEARTBEAM INC is BEAT and it is listed on the Nasdaq exchange.
On which exchange is BEAT stock listed?
BEAT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HEARTBEAM INC stock?
8 analysts have analysed BEAT and the average price target is 5.1 USD. This implies a price increase of 188.14% is expected in the next year compared to the current price of 1.77. Check the HEARTBEAM INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HEARTBEAM INC worth?
HEARTBEAM INC (BEAT) has a market capitalization of 59.70M USD. This makes BEAT a Micro Cap stock.
How many employees does HEARTBEAM INC have?
HEARTBEAM INC (BEAT) currently has 15 employees.
What are the support and resistance levels for HEARTBEAM INC (BEAT) stock?
HEARTBEAM INC (BEAT) has a support level at 1.94 and a resistance level at 1.97. Check the full technical report for a detailed analysis of BEAT support and resistance levels.
Should I buy HEARTBEAM INC (BEAT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BEAT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BEAT, evaluating the profitability, health, valuation and growth aspects
- HEARTBEAM INC (BEAT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HEARTBEAM INC (BEAT) Sales and EPS estimates to see what analysts future expectations are.
- HEARTBEAM INC (BEAT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HEARTBEAM INC (BEAT) Insider and Institutional Ownership to learn about the owners and their transactions.
- HEARTBEAM INC (BEAT) Stock Chart to make your own analysis
- HEARTBEAM INC (BEAT) Latest news and press-releases to stay up to date.
Does HEARTBEAM INC (BEAT) stock pay dividends?
BEAT does not pay a dividend.
When does HEARTBEAM INC (BEAT) report earnings?
HEARTBEAM INC (BEAT) will report earnings on 2025-05-08, after the market close.
What is the Price/Earnings (PE) ratio of HEARTBEAM INC (BEAT)?
HEARTBEAM INC (BEAT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.73).
What is the Short Interest ratio of HEARTBEAM INC (BEAT) stock?
The outstanding short interest for HEARTBEAM INC (BEAT) is 0.45% of its float. Check the ownership tab for more information on the BEAT short interest.
BEAT Technical Analysis
BEAT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BEAT. While BEAT seems to be doing ok healthwise, there are quite some concerns on its profitability.
BEAT Financial Highlights
Over the last trailing twelve months BEAT reported a non-GAAP Earnings per Share(EPS) of -0.73. The EPS increased by 22.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -593.65% | ||
| ROE | -1175.82% | ||
| Debt/Equity | 0 |
BEAT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to BEAT. The Buy consensus is the average rating of analysts ratings from 8 analysts.